Yuanfang He
Biographic Data
| ID | 7263290 |
|---|---|
| NAME | Yuanfang He |
| GIVEN NAMES | Yuanfang |
| FAMILY NAME | He |
| SIGNATURE | HE Y |
| AFFILIATIONS | Zhejiang Chinese Medical University |
| ORCID | 0000-0001-9414-2787 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Epidemiological trends and pathogen analysis of pediatric acute respiratory infections in Hanzhong Hospital, China: Insights from 2023 to 2024
Background Acute respiratory infections (ARIs) are a leading cause of morbidity in children. Understanding the distribution of respiratory pathogens is crucial for effective prevention and treatment. This study analyzed the prevalence and epidemiological characteristics of ARIs in children from 2023 to 2024. Methodology This study included 9,294 children aged 0–18 years with ARI symptoms who were treated between July 2023 and August 2024. Respira…
Qinghao-Biejia Herb Pair attenuates SLE atherosclerosis by regulating macrophage polarization via Abca1/G1-mediated cholesterol efflux
QB demonstrates clear efficacy for treating SLE-AS, and its therapeutic mechanism may involve the regulation of macrophage phenotypes by promoting cholesterol efflux
Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9/MyD88 activation
No prominent works on this page.
Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9/MyD88 activation
Qinghao-Biejia Herb Pair attenuates SLE atherosclerosis by regulating macrophage polarization via Abca1/G1-mediated cholesterol efflux
QB demonstrates clear efficacy for treating SLE-AS, and its therapeutic mechanism may involve the regulation of macrophage phenotypes by promoting cholesterol efflux
Epidemiological trends and pathogen analysis of pediatric acute respiratory infections in Hanzhong Hospital, China: Insights from 2023 to 2024
Background Acute respiratory infections (ARIs) are a leading cause of morbidity in children. Understanding the distribution of respiratory pathogens is crucial for effective prevention and treatment. This study analyzed the prevalence and epidemiological characteristics of ARIs in children from 2023 to 2024. Methodology This study included 9,294 children aged 0–18 years with ARI symptoms who were treated between July 2023 and August 2024. Respira…
Medicine (3 works) · ABCA1 (2 works) · Atherosclerosis and Cardiovascular Diseases (2 works) · Biochemistry (2 works) · Biology (2 works) · Cholesterol (2 works) · Endocrinology (2 works) · Pharmacology (2 works) · ABCG1 (1 works) · Chemistry (1 works)